Linkage of product license-insurance price registration eyed

Published: 2008-08-18 07:00:00

Updated: 2008-08-18 07:00:00

The Korea Drug Research Association has called for the government to shorten the period of assessing the possible health insurance prices of all medicines, when these drugs are approved by the Korea Food and Drug Administration.

A KDRA official said that if this is the case, drug makers will b...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK